| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.55▲ | 1.59▼ | 1.59▼ | 1.67▼ | 1.94▼ |
| MA10 | 1.60▼ | 1.65▼ | 1.65▼ | 1.81▼ | 2.05▼ |
| MA20 | 1.67▼ | 1.72▼ | 1.73▼ | 1.92▼ | 1.95▼ |
| MA50 | 1.79▼ | 1.85▼ | 1.86▼ | 2.00▼ | 1.66▼ |
| MA100 | 1.89▼ | 1.91▼ | 1.99▼ | 1.98▼ | 1.12▲ |
| MA200 | 2.00▼ | 2.15▼ | 2.13▼ | 1.88▼ | 1.43▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.010▼ | -0.015▼ | -0.016▼ | -0.048▼ | -0.064▼ |
| RSI | 27.833▼ | 28.521▼ | 27.720▼ | 31.497▼ | 44.198▼ |
| STOCH | 9.991▼ | 3.401▼ | 3.401▼ | 12.940▼ | 55.949 |
| WILL %R | -79.592▼ | -79.592▼ | -80.000▼ | -89.394▼ | -75.641▼ |
| CCI | -78.336 | -135.180▼ | -134.001▼ | -159.395▼ | -91.549 |
|
Monday, February 09, 2026 05:33 AM
IN8bio (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (?d) T cell therapies and T cell engagers for cancer and ...
|
|
Monday, February 09, 2026 05:17 AM
Photo Kate Rochlin, Ph.D., President & COO NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- IN8bio (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ ) T cell ...
|
|
Tuesday, February 03, 2026 05:16 AM
IO360° Conference Date: Thursday, February 12, 2026 Time: 1:20 p.m. – 1:40 p.m. ET Session: IO Clinical Advancements Plenary Presentation title: IN8bio’s Unique DeltEx Drug Resistant Immunotherapy ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/02/26 | 1.63 | 1.69 | 1.48 | 1.55 | 59,157 |
| 19/02/26 | 1.67 | 1.68 | 1.58 | 1.60 | 51,587 |
| 18/02/26 | 1.73 | 1.7899 | 1.66 | 1.68 | 34,102 |
| 17/02/26 | 1.75 | 1.79 | 1.72 | 1.72 | 42,003 |
| 13/02/26 | 1.814 | 1.90 | 1.78 | 1.78 | 29,567 |
| 12/02/26 | 1.97 | 2.05 | 1.70 | 1.85 | 49,340 |
| 11/02/26 | 1.92 | 2.02 | 1.86 | 1.99 | 41,713 |
| 10/02/26 | 1.99 | 2.05 | 1.89 | 1.91 | 25,966 |
| 09/02/26 | 1.96 | 2.07 | 1.92 | 2.00 | 58,719 |
| 06/02/26 | 1.90 | 2.03 | 1.85 | 1.99 | 36,804 |
|
|
||||
|
|
||||
|
|